YZE-19049-83792
4 vaccinations
2 coded responses
36 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 926 / CA
- Registered
- 2021-03-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
AQU-14448-82729
Child or adolescent in my care · Female · 2021-12-01
Timeline
-
2021-03-08
Registered in v-safe
-
2021-03-08
Dose 1 — Pfizer-BioNTech
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
-
2021-03-14
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Muscle or body aches, NauseaAdult check-in
- 2021-03-24
-
2021-03-29
Dose 2 — Pfizer-BioNTech
- 2021-03-29
-
2021-03-30
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-05
- 2021-04-12
- 2021-04-22
- 2021-04-26
- 2021-05-03
- 2021-05-10
- 2021-06-29
- 2021-09-27
-
2021-11-12
Dose 3 — Pfizer-BioNTech
- 2021-12-01
- 2021-12-03
- 2021-12-10
- 2021-12-17
- 2021-12-24
- 2022-02-11
-
2022-05-13
Survey response — 6 months, dose 3MedDRA: COVID-19, Dyspepsia, Gastrooesophageal reflux disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: COVID & severe heartburn/ GerdMedDRA releases: 2024-11 · check-in free text available
-
2022-05-13
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
- 2022-05-16
-
2022-09-15
Dose 4 — Pfizer-BioNTech
- 2022-09-20
- 2022-09-24
- 2022-09-29
- 2022-10-08
-
2022-10-13
Survey response — day 28, dose 4MedDRA: Influenza — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Flu symptomsMedDRA releases: 2024-11 · check-in free text available
- 2022-10-27
- 2022-12-15
- 2023-03-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-08 | Pfizer-BioNTech | |
| 2 | 2021-03-29 | Pfizer-BioNTech | |
| 3 | 2021-11-12 | Pfizer-BioNTech | No |
| 4 | 2022-09-15 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-05-13 | Unsuccessful |
Free text
Release 11 — 6 months, dose 3
Symptoms: COVID & severe heartburn/ Gerd
Release 12 — day 28, dose 4
Symptoms: Flu symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Dyspepsia | · | · | ✓ |
| SD | Gastrooesophageal reflux disease | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release